Literature DB >> 86416

[Plasma level and effectiveness of propafenone and its organ distribution (author's transl)].

H Blanke, B Aschbrenner, K R Karsch, H Kreuzer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 86416     DOI: 10.1055/s-0028-1103950

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  7 in total

1.  Tissue distribution of propafenone in the rat after intravenous administration.

Authors:  J Fernández; L Lligoña; A Puigdemont; R Guitart; J L Riu; M Arboix
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jan-Mar       Impact factor: 2.441

2.  Beta-blocking and electrophysiological effects of propafenone in volunteers.

Authors:  H Müller-Peltzer; G Greger; G Neugebauer; M Hollmann
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 3.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

Review 4.  Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Authors:  D W Harron; R N Brogden
Journal:  Drugs       Date:  1987-12       Impact factor: 9.546

5.  The metabolic fate of 2H-labelled propafenone in man.

Authors:  H G Hege; M Hollmann; S Kaumeier; H Lietz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

Review 6.  New antiarrhythmic drugs.

Authors:  P F Nestico; J Morganroth; L N Horowitz
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of propafenone.

Authors:  J T Hii; H J Duff; E D Burgess
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.